ALPN

Alpine Immune Sciences Stock Price

11.33
0.13 (1.16%)
Upgrade to Real-Time
Afterhours (Closed)
11.33
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Alpine Immune Sciences Inc ALPN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 1.16% 11.33 20:00:00
Open Price Low Price High Price Close Price Prev Close
11.17 10.7927 11.54 11.33 11.20
Bid Price Ask Price Spread News
2.00 11.33 9.33 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
495 122,190 $ 11.19 $ 1,367,347 151,366 2.58 - 18.81
Last Trade Time Type Quantity Stock Price Currency
16:08:22 average 90,890 $ 11.33 USD

Alpine Immune Sciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 269.69M 23.80M 10.31M $ 1.74M $ - -2.29 -9.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Alpine Immune Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALPN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.8811.6210.6711.0277,7260.454.14%
1 Month12.8814.479.7811.9879,742-1.55-12.03%
3 Months13.7914.609.7812.36128,582-2.46-17.84%
6 Months8.7316.377.2112.30103,2292.6029.78%
1 Year2.7918.812.5811.05268,3968.54306.09%
3 Years8.047618.812.0510.39101,1503.2840.79%
5 Years4.3418.812.007.11115,3076.99161.06%

Alpine Immune Sciences Description

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing modern, protein-based immunotherapies targeting the immune synapse to treat cancer, inflammation, and other diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.


Your Recent History
NASDAQ
ALPN
Alpine Imm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.